In 2000, NIH recruited Graham to evaluate vaccine candidates. He insisted on keeping a research lab. With space for two dozen scientists, his lab focused on creating vaccines for three categories of respiratory viruses: influenza, coronaviruses, and a highly contagious pathogen called respiratory syncytial virus (RSV), which ended up playing a key role in the development of a Covid vaccine.
